Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/42283
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Pharmacogenetics of opioids
Author: Somogyi, A.
Barratt, D.
Coller, J.
Citation: Clinical Pharmacology & Therapeutics, 2007; 81(3):429-444
Publisher: Mosby Inc
Issue Date: 2007
ISSN: 0009-9236
1532-6535
Statement of
Responsibility: 
Andrew A Somogyi, Daniel T Barratt and Janet K Coller
Abstract: Opioids are used for acute and chronic pain and dependency. They have a narrow therapeutic index and large interpatient variability in response. Genetic factors regulating their pharmacokinetics (metabolizing enzymes, transporters) and pharmacodynamics (receptors and signal transduction elements) are contributors to such variability. The polymorphic CYP2D6 regulates the O-demethylation of codeine and other weak opioids to more potent metabolites with poor metabolizers having reduced antinociception in some cases. Some opioids are P-glycoprotein substrates, whereas, ABCB1 genotypes inconsistently influence opioid pharmacodynamics and dosage requirements. Single-nucleotide polymorphisms in the mu opioid receptor gene are associated with increasing morphine, but not methadone dosage requirements and altered efficacy of mu opioid agonists and antagonists. As knowledge regarding the interplay between genes affecting opioid pharmacokinetics including cerebral kinetics and pharmacodynamics increases, our understanding of the role of pharmacogenomics in mediating interpatient variability in efficacy and side effects to this important class of drugs will be better informed. Opioid drugs as a group have withstood the test of time in their ability to attenuate acute and chronic pain. Since the isolation of morphine in the early 1800s by Friedrich Sertürner, a large number of opioid drugs beginning with modification of the 4,5-epoxymorphinan ring structure were developed in order to improve their therapeutic margin, including reducing dependence and tolerance, ultimately without success.
Keywords: Animals; Humans; Pain; Receptors, Opioid; Analgesics, Opioid; Pain Measurement; Pharmacogenetics; Polymorphism, Genetic
RMID: 0020070434
DOI: 10.1038/sj.clpt.6100095
Published version: http://www.nature.com/clpt/journal/v81/n3/full/6100095a.html
Appears in Collections:Pharmacology publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.